BRICE WAGNER: Open Payments
NPI 1568037232 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 19 payments from 8 companies in 2025. Trend: 2023 $659 · 2024 $851 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $177 |
| Abbott Laboratories | 1 | $135 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Edwards Lifesciences Corporation | 1 | $23 |
| Novo Nordisk Inc | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: ETERNA, REPATHA, OTEZLA, LEQVIO, Wegovy, CAMZYOS, NEXLETOL, MOUNJARO.
Industry payments across LA — which companies pay providers there.
